Your browser is out of date!

You are accessing this website using a legacy browser. You may find that certain parts of the new GP Website do not work as expected. We recommend upgrading your browser to continue.

If you are based within a GP practice please contact the GPIT Helpdesk on 020 3816 3258 or email nelondonicb.cahpractitioners@nhs.net to carry out the upgrade

Prostate Cancer in Primary Care

Add to CPD Start a discussion

Book Now

You must be logged in to your account in order to register for this event.

Register

or

Sign In

Prostate Cancer in Primary Care

  • Friday, 29th November 2024, 1.00pm – 2.00pm
  • Online Event

Revise the rationale for prostate specific antigen (PSA) testing  in the context of the latest evidence   

Understand the role of new oral therapy which will replace luteinizing hormone-releasing hormone (LHRH)injections    

Describe the new USC pathway update for prostate, testicular and renal cancer  

Implement stratified  follow up for prostate cancer in primary care 

 

Speakers:

Ms Jhumur Pati  

Sessions

Prostate Cancer in Primary Care — Afternoon

Friday, 29th November 2024 / 1.00pm

As above

 

You're adding a event to your CPD log. The title of this entry will be Prostate Cancer in Primary Care. You can change the description, reflection or CPD Credit Hours at any time from within My CPD

Add to CPD

When you attend an event booked through the North East London ICB (City & Hackney) GP Website, we'll add the event details to your CPD section automatically.

External Link

This is an external link. Continuing will take you away from the North East London ICB (City & Hackney) GP Website. Please be aware that some external resources may be restricted to NHS Secure Network connections only.

Continue

Page Feedback

Report a problem or suggestion using this facility. When describing your problem or suggestion, be as descriptive as possible and include any specific error messages you may see.

Please note

This website is for healthcare professionals only. It is not intended for public use.

Continue